Stay updated on Nivolumab vs Temozolomide in GBM Clinical Trial
Sign up to get notified when there's something new on the Nivolumab vs Temozolomide in GBM Clinical Trial page.

Latest updates to the Nivolumab vs Temozolomide in GBM Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedMinor revision updates were applied: v3.4.2 added and v3.4.1 removed, with no user-facing content or functionality changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check20 days agoChange DetectedThe page now displays Revision: v3.4.1, replacing the previous Revision: v3.4.0 in the metadata. This is a minor versioning update and does not alter study content or functionality.SummaryDifference0.0%

- Check27 days agoChange DetectedThe page now shows a glossary and QC-related metadata (Last Update Submitted that Met QC Criteria) along with No FEAR Act Data and Revision: v3.4.0. The older QC field capitalization (Last Update Submitted that met QC Criteria), the No FEAR Act data, and Revision: v3.3.4 were removed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision: v3.3.4 replaced the prior v3.3.3 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedAdded a detailed Locations section listing participating sites across the United States, Canada, United Kingdom, Australia, and Japan. This helps potential participants identify nearby sites and understand where the study is being conducted.SummaryDifference2%

- Check85 days agoChange DetectedRevision tag updated from v3.3.1 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Nivolumab vs Temozolomide in GBM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Temozolomide in GBM Clinical Trial page.